| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 38 |
| 1 | ADALIMUMAB | 29 |
| 2 | ASPIRIN | 27 |
| 3 | GABAPENTIN | 27 |
| 4 | ASPIRIN 325 MG | 26 |
| 5 | ASPIRIN 81 MG | 26 |
| 6 | ACETAMINOPHEN | 25 |
| 7 | ALENDRONATE SODIUM | 25 |
| 8 | IBUPROFEN | 25 |
| 9 | ALPRAZOLAM | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 3 | 0.0238 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 7 | 0.0025 |
| 2 | HYDROCODONE BITARTRATE AND IBUPROFEN | 1 | 0.0021 |
| 3 | DICHLORPHENAMIDE | 3 | 0.0018 |
| 4 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 5 | PSYLLIUM HUSK | 2 | 0.0015 |
| 6 | GIVOSIRAN SODIUM | 2 | 0.0013 |
| 7 | ERGOCALCIFEROL | 38 | 0.0013 |
| 8 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 9 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 1 | Benzodiazepine [EPC] | 65 |
| 2 | Corticosteroid [EPC] | 37 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 4 | Proton Pump Inhibitor [EPC] | 28 |
| 5 | Vitamin C [EPC] | 24 |
| 6 | Opioid Agonist [EPC] | 20 |
| 7 | Atypical Antipsychotic [EPC] | 19 |
| 8 | Expectorant [EPC] | 19 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 1 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 1 | 0.0005 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0004 |
| 4 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 5 | Cholinergic Muscarinic Agonist [EPC] | 1 | 0.0004 |
| 6 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |